CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Clinical Trials Arena
Original article

FDA clears Quoin Pharmaceuticals’ QRX003 IND for Phase II PSS trial

Phase 2QRX003
Related Companies

Read the original article

Published by Clinical Trials Arena on July 10, 2026 9:18 AM

Read Original